| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |